Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
January 17, 2018
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives
Philipp Backhaus, Benjamin Noto, Nemanja Avramovic, et al.
Annals of Hematology
|
September 25, 2013
Visceral leishmaniasis clinically mimicking lymphoma
Georg Evers, Michele Pohlen, Wolfgang E Berdel, et al.
BMC Cancer
|
September 11, 2021
<sup>18</sup>F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
Wolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Nuklearmedizin. Nuclear Medicine
|
July 22, 2020
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma
Michael Müther, Wolfgang Roll, Benjamin Brokinkel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 12, 2012
Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT
Kambiz Rahbar, Harald Seifarth, Michael Schäfers, et al.
Annals of Nuclear Medicine
|
March 20, 2021
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
Sergiu Scobioala, Christopher Kittel, Heidi Wolters, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 16, 2008
Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound
Verena Schick, Christiane Franzius, Torsten Beyna, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 10, 2016
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer
Alexis Vrachimis, Lars Stegger, Christian Wenning, et al.
Cancer Biomarkers : Section a of Disease Markers
|
May 18, 2011
PET in the diagnosis and management of patients with brain metastasis: current role and future perspectives
Yannic Waerzeggers, Kambiz Rahbar, Burkhard Riemann, et al.
Neurosurgery
|
April 13, 2002
Prognostic significance of amino acid transport imaging in patients with brain tumors
Matthias Weckesser, Peter Matheja, Antje Schwarzrock, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
European Journal of Nuclear Medicine and Molecular Imaging
|
January 17, 2018
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives
Philipp Backhaus, Benjamin Noto, Nemanja Avramovic, et al.
Annals of Hematology
|
September 25, 2013
Visceral leishmaniasis clinically mimicking lymphoma
Georg Evers, Michele Pohlen, Wolfgang E Berdel, et al.
BMC Cancer
|
September 11, 2021
<sup>18</sup>F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
Wolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Nuklearmedizin. Nuclear Medicine
|
July 22, 2020
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma
Michael Müther, Wolfgang Roll, Benjamin Brokinkel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 12, 2012
Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT
Kambiz Rahbar, Harald Seifarth, Michael Schäfers, et al.
Annals of Nuclear Medicine
|
March 20, 2021
Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions
Sergiu Scobioala, Christopher Kittel, Heidi Wolters, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 16, 2008
Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound
Verena Schick, Christiane Franzius, Torsten Beyna, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 10, 2016
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer
Alexis Vrachimis, Lars Stegger, Christian Wenning, et al.
Cancer Biomarkers : Section a of Disease Markers
|
May 18, 2011
PET in the diagnosis and management of patients with brain metastasis: current role and future perspectives
Yannic Waerzeggers, Kambiz Rahbar, Burkhard Riemann, et al.
Neurosurgery
|
April 13, 2002
Prognostic significance of amino acid transport imaging in patients with brain tumors
Matthias Weckesser, Peter Matheja, Antje Schwarzrock, et al.
Page
of 10